Triazolo compounds useful as diacylglycerol acyltransferase1 inhibitor WO2009126624

Expert Opinion on Therapeutic Patents

Volumn 20, Issue 8, 2010, Pages 1097-1102

  Matsuda, Daisuke ^a   Tomoda, Hiroshi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

DGAT; Obesity; Triacylglycerol; Triazolopyridine

Indexed keywords

ACYLTRANSFERASE INHIBITOR; AMIDEPSINE; BAY 744113; DIACYLGLYCEROL ACYLTRANSFERASE 1; PF 04415060; ROSELIPIN; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; XANTHOHUMOL; ANTIOBESITY AGENT; DGAT1 PROTEIN, HUMAN; DIACYLGLYCEROL ACYLTRANSFERASE; ENZYME INHIBITOR; TRIACYLGLYCEROL;

CLINICAL TRIAL; DRUG INHIBITION; DRUG MECHANISM; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; IC 50; INSECT CELL; OBESITY; REVIEW; STRUCTURE ACTIVITY RELATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; PATENT;

ANIMALS; ANTI-OBESITY AGENTS; DIACYLGLYCEROL O-ACYLTRANSFERASE; ENZYME INHIBITORS; HUMANS; MOLECULAR STRUCTURE; PATENTS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP; TRIAZOLES; TRIGLYCERIDES;

EID: 77954908327     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.2010.493877     Document Type: Review

References (50)

1. Lehner R, Kuksis A. Biosynthesis of triacylglycerols. Prog Lipid Res 1996;35:169-201
2. Cases S, Smith SJ, Zheng Y-W, et al. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci USA 1998;95:13018-13023
3. Oelkers P, Behari A, Cromley D, et al. Characterization of two human genes encoding acyl coenzyme A: cholesterol acyltransferase-related enzymes. J Biol Chem 1998;273:26765-26771
4. Cases S, Stone SJ, Zhou P, et al. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J Biol Chem 2001;276:38870-38876
5. Stone SJ, Myers HM, Watkins SM, et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004;279:11767-11776
6. Smith SJ, Cases S, Jensen DR, et al. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking DGAT. Nat Genet 2000;25:87-90
7. Chen HC, Smith SJ, Ladha Z, et al. Increased insulin and leptin sensitivity in mice lacking acyl-CoA: diacylglycerol acyltransferase 1. J Clin Invest 2002;109:1049-1055
8. Chen HC, Ladha Z, Smith SJ, et al. Analysis of energy expenditure at different ambient temperatures in mice lacking DGAT1. Am J Physiol Endocrinol Metab 2003;284:E213-8
9. Chen HC, Farese RV Jr. Inhibition of triglyceride synthesis as a treatment strategy for obesity. Arterioscler Thromb Vasc Biol 2005;25:482-486
10. Seethala R, Peterson T, Dong J, et al. A simple homogeneous scintillation proximity assay for acyl-coenzyme A: diacylglycerol acyltransferase. Anal Biochem 2008;383:144-150
11. King AJ, Judd AS, Souers AJ. Inhibitors of diacylglycerol acyltransferase: a review of 2008 patents. Expert Opin Ther Pat 2010;20:19-29
12. Bayer Pharmaceuticals Corporation. Preparation and use of aryl alkyl acid derivatives for the treatment of obesity. WO100881; 2004
13. Bayer Pharmaceuticals Co. Preparation of aryl alkyl acid derivatives for the treatment of obesity and related diseases. WO06113919; 2006
14. Japan Tobacco, Inc. Anorectic compounds. WO072740; 2005
15. Takeda Pharmaceutical Company. Furan or thiophene derivative and medicinal use thereof. WO022551; 2004
16. Astrazeneca AB. Use of sulfonamide compounds for the treatment of diabetes and/or obesity. WO044250; 2005
17. F. Hoffmann-La Roche AG. Inhibitors of diacylglycerol acyltransferase (DGAT). WO082010; 2006
18. F. Hoffmann-La Roche AG. Diacylglycerol acyltransferase inhibitors. WO120125; 2006
19. VIA Pharmaceuticals, Inc. 1-(Indazol-5-yl)-ureas as diacylglycerol acyltransferase inhibitors. WO071483; 2009
20. Bristol-Myers Squibb Co. Triazolopyridine compounds useful as DGAT1 inhibitors. WO126861; 2009
21. Taisho Pharmaceutical Co., Ltd. Heteroarylbenzene compounds. WO011285; 2009
22. Astrazeneca AB. Oxadiazole derivatives as DGAT inhibitors. WO024821; 2009
23. Tularic, Inc., Japan Tobacco, Inc. Preparation of pyrrolo[1,2-b] pyridazines for use in pharmaceutical compositions which modulate the activity of proteins involved in lipid metab. and cell proliferation. WO05013907; 2005
24. Novartis AG. Organic compounds. WO007046; 2010
25. Novartis AG. Oxadiazole-and oxazole-substituted benzimidazole-and indole-derivatives as DGAT1 inhibitors. WO040410; 2009
26. Available from: http://www.prdomain. com/companies/P/Pfizer/newsreleases/ 82845084.htm
27. Available from: http://clinicaltrials.gov/ct2/show/NCT00959426?term= bristol+myers+diabete+pfizer&rank=1
28. Available from: http://www.prdomain.com/companies/P/Pfizer/newsreleases/ 82845084.htm
29. Matsuda D, Tomoda H. DGAT inhibitors for obesity. Curr Opin Investig Drugs 2007;8:836-841
30. Tomoda H, Omura S. Potential therapeutics for obesity and atherosclerosis: inhibitors of neutral lipid metabolism from microorganisms. Pharmacol Ther 2007;115:375-389
31. Tomoda H, Ito M, Tabata N, et al. Amidepsines, inhibitors of diacylglycerol acyltransferase produced by Humicola sp. FO-2942. I. Production, isolation and biological properties. J Antibiot 1995;48:937-941
32. Tomoda H, Tabata N, Ito M, et al. Amidepsines, inhibitors of diacyl glycerol acyltransferase produced by Humicola sp. FO-2942. II. Structure elucidation of amidepsines A, B and C. J Antibiot 1995;48:942-947
33. Tomoda H, Yamaguchi Y, Tabata N, et al. Amidepsine E, an inhibitor of diacylglycerol acyltransferase produced by Humicola sp. FO-5969. J Antibiot 1996;49:929-931
34. Omura S, Tomoda H, Tabata N, et al. Roselipins, novel fungal metabolites having a highly methylated fatty acid modified with a mannose and an arabinitol. J Antibiot 1999;52:586-589
35. Tomoda H, Ohyama Y, Abe T, et al. Roselipins, inhibitors of diacylglycerol acyltransferase, produced by Gliocladium roseum KF-1040. J Antibiot 1999;52:689-694 (Pubitemid 29431314)
36. Tabata N, Ohyama Y, Tomoda H, et al. Structure elucidation of roselipins, inhibitors of diacylglycerol acyltransferase produced by Gliocladium roseum KF-1040. J Antibiot 1999;52:815-826 (Pubitemid 29476358)
37. Elix JA, Jayanthi VK, Leznoff CC. 2,4-Di-O-methylgyrophoric acid and 2,4,5-tri-O-methylhiascic acid. New tridepsides from Parmelia damaziana. Aust J Chem 1981;34:1757-1761
38. Tabata N, Ito M, Tomoda H, et al. Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry 1997;46:683-687
39. Ko JS, Rho MC, Chung MY, et al. Quinolone alkaloids, diacylglycerol acyltransferase inhibitors from the fruits of Evodia rutaecarpa. Planta Med 2002;68:1131-1133
40. Ko JS, Ko JS, Ryu SY, et al. Inhibitory activity of diacylglycerol acyltransferase by tanshinones from the root of Salvia miltiorrhiza. Arch Pharm Res 2002;25:446-448
41. Lee SW, Kim K, Rho MC, et al. New polyacetylenes, DGAT inhibitors from the roots of Panax ginseng. Planta Med 2004;70:197-200
42. Chung MY, Rho MC, Ko JS, et al. In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens. Planta Med 2004;70:258-260
43. Dat NT, Cai XF, Rho MC, et al. The inhibition of diacylglycerol acyltransferase by terpenoids from Youngia koidzumiana. Arch Pharm Res 2005;28:164-168
44. Chung MY, Rho MC, Lee SW, et al. Inhibition of diacylglycerol acyltransferase by betulinic acid from Alnus hirsuta. Planta Med 2006;72:267-269
45. Lee SW, Rho MC, Park HR, et al. Inhibition of diacylglycerol acyltransferase by alkamides isolated from the fruits of Piper longum and Piper nigrum. J Agric Food Chem 2006;54:9759-9763
46. Inokoshi J, Kawamoto K, Takagi Y, et al. Expression of two human acyl-CoA: diacylglycerol acyltransferase isozymes in yeast and selectivity of microbial inhibitors toward the isozymes. J Antibiot (Tokyo) 2009;62:51-54
47. Stone SJ, Myers HM, Watkins SM, et al. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J Biol Chem 2004;279:11767-11776
48. Yu XX, Murray SF, Pandey SK, et al. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice. Hepatology 2005;42:362-371
49. Koliwad SK, Streeper RS, Monetti M, et al. DGAT1-dependent triacylglycerol storage by macrophages protects mice from diet-induced insulin resistance and inflammation. J Clin Invest 2010;120:756-767
50. Listenberger LL, Han X, Lewis SE, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003;100:3077-3082